Avenzo Therapeutics logo

Avenzo Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

Undisclosed


Avenzo Therapeutics is a biotechnology company developing oncology therapies, including a CDK2 inhibitor for advanced solid tumors and HR+/HER2-negative metastatic breast cancer.

Total Funding

$386M

Headquarters

San Diego, USA

Founded

N/A

Focus Areas

Biotechnology
Oncology
CDK2 inhibitor
Phase 1 study
Solid tumors
Metastatic breast cancer

Investors

OrbiMed logo
Lilly Asia Ventures logo
New Enterprise Associates logo
SR One logo
Deep Track Capital logo
Sands Capital logo
Surveyor Capital logo
Foresite Capital logo
Quan Capital logo
Sofinnova Investments logo
INCE Capital logo
Delos Capital logo
TF Capital logo